Post-Traumatic Epilepsy Initiative

Genetic and Protein Biomarkers of Post-Traumatic Epilepsy to Improve Prediction of PTE: A Prospective Study in an Enriched Patient Population

Pavel Klein, MD
Mid-Atlantic Epilepsy and Sleep Center, LLC

Post-traumatic epilepsy does not develop until weeks or years after a traumatic brain injury, offering a window of opportunity for preventative treatment. However, it is currently not possible to predict who will develop epilepsy following a traumatic brain injury, nor do any preventative measures exist. In fact, there are currently no clinical studies being conducted that seek to prevent the development of post-traumatic epilepsy, despite the availability of a number of approved drugs with antiepileptogenic properties. A major reason for the lack of clinical trials in this area is the relatively low rate and unpredictability of post-traumatic epilepsy among individuals with a traumatic brain injury, making such studies large and costly.

Dr. Pavel Klein and his team seek to address this problem by examining a group of “high-risk” patients with a greater chance of developing post-traumatic epilepsy. Using this group of individuals, Dr. Klein and his team will search for biomarkers for the development of post-traumatic epilepsy by determining if there are indicators that can be measured in the EEG signature, MRI or blood that might predict increased risk of a person developing post-traumatic epilepsy. By identifying ways to identify individuals most at risk of developing post-traumatic epilepsy, the team will pave the way for the development of therapies to prevent its development in the first place.


    Join our email list for the
    latest epilepsy research news,
    discoveries, and more.